esophageal squamous cell carcinoma
Tevimbra Approved for Some Patients With Unresectable or Metastatic ESCC
The FDA has approved tislelizumab for the first-line treatment of unresectable or metastatic esophageal squamous ...
MARCH 10, 2025
Tevimbra Approved for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemo
The FDA approved tislelizumab-jsgr as monotherapy for certain adult patients with esophageal squamous cell ...
MARCH 19, 2024
New ASGE Guideline Gives Parameters for ESD in the Upper GI Tract
The American Society for Gastrointestinal Endoscopy has come out with its first-ever guidelines on endoscopic ...
DECEMBER 6, 2023
Keytruda Monotherapy Granted Esophageal Cancer Indication
The FDA approved pembrolizumab (Keytruda, Merck) monotherapy for patients with recurrent locally advanced or ...
AUGUST 1, 2019
Load more